Recombinant Adenoviral Human p53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable, Locally Advanced Head and Neck Cancer - a Open-labeled Randomized Phase 2 Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The objectives of this study are to investigate the efficacy and safety of rAd-p53 gene combined with radio- and chemo-therapy vs. radio- and chemo- therapy only in treatment of unresectable, locally advanced head and neck cancer. This is a phase 2, open labeled, and active-controlled study.
Epistemonikos ID: 05dccad1ebd8686228ea1f7bf731d3216294cb56
First added on: May 12, 2024